Contemporary Management of HIV: Modifying Antiretroviral Therapy in Virologically Suppressed Patients and Those With Treatment Failure
Source: Contemporary Management of HIV

Slideset

Contemporary Management of HIV: Modifying Antiretroviral Therapy in Virologically Suppressed Patients and Those With Treatment Failure

In this downloadable slideset, W. David Hardy, MD, and Program Director Eric S. Daar, MD review key data and optimal approaches for modifying ART in patients who are virologically suppressed or have experienced treatment failure.
Format: Microsoft PowerPoint (.ppt)
File size: 1.89 MB
Date posted: 1/20/2017
  • My Approach to First-line ART for Patients With High Cardiovascular Disease Risk

    William G. Powderly MD - 10/6/2015    4 comments / Last Comment: 11/8/2015
    When treating HIV in patients with risk factors for CVD, selecting the optimal ART regimen is only part of the equation.
  • ART in Older Patients: How I Manage Drug–Drug Interactions With Concomitant Medications

    Anton L. Pozniak MD, FRCP - 10/20/2015    16 comments / Last Comment: 5/10/2016
    As our patients age, they experience metabolic changes and more frequently develop conditions such as bone mineral density loss, cardiovascular disease, diabetes, and malignancies, all of which will affect the choice of first-line ART.
  • Switch Strategies in Virologically Suppressed Patients: My Take on New Data From Recent Scientific Meetings

    Anton L. Pozniak MD, FRCP - 1/22/2016    15 comments / Last Comment: 11/14/2016
    Several recent studies have highlighted new approaches to ART switching. Some may expand our options for optimizing long-term virologic suppression in our patients; each should be scrutinized carefully before incorporating into practice.
  • Selecting First-line Antiretroviral Therapy in Older Patients: New Data, New Options, Key Considerations

    Giovanni Guaraldi MD - 12/16/2015    2 comments / Last Comment: 2/10/2016
    The management of ART in patients aging with HIV requires clinicians to maintain a detailed knowledge of physical and psychological patient health in order to tailor the most appropriate ART regimen.
  • Clinical Case: Estimating Cardiovascular Disease Risk With the ASCVD Event Calculator

    David A. Wohl MD - 9/16/2015    1 comment / Last Comment: 9/17/2015
    How I used the ASCVD event calculator to estimate CVD risk for an HIV-infected patient with stably suppressed HIV-1 RNA.